
inbiome is a pioneer in molecular diagnostics, offering a patented Molecular Culture technology that significantly accelerates bacterial diagnostics and microbiome analysis. Their proprietary profiling technique reliably characterizes complex bacterial communities, detecting all bacteria within hours, offering a radical improvement over traditional culture methods. This technology provides more sensitive and accurate diagnoses, reducing false negatives and enabling diagnoses within hours instead of days, leading to faster patient recovery, fewer complications, and reduced healthcare costs. Their services cater to healthcare providers, pharmaceutical companies, and the food & beverage industry, with applications in clinical bacterial diagnostics, quality control testing, and monitoring bacterial compositions. inbiome's laboratory is ISO 13485 certified and approved for COVID-19 diagnostics.

inbiome is a pioneer in molecular diagnostics, offering a patented Molecular Culture technology that significantly accelerates bacterial diagnostics and microbiome analysis. Their proprietary profiling technique reliably characterizes complex bacterial communities, detecting all bacteria within hours, offering a radical improvement over traditional culture methods. This technology provides more sensitive and accurate diagnoses, reducing false negatives and enabling diagnoses within hours instead of days, leading to faster patient recovery, fewer complications, and reduced healthcare costs. Their services cater to healthcare providers, pharmaceutical companies, and the food & beverage industry, with applications in clinical bacterial diagnostics, quality control testing, and monitoring bacterial compositions. inbiome's laboratory is ISO 13485 certified and approved for COVID-19 diagnostics.